INVE Technologies launches $20M Dutch auction tender offer for shares

INVE Technologies, Inc. (NASDAQ: INVE) has commenced a modified Dutch auction self-tender offer to repurchase up to $20 million of its common stock, with a price range of $2.85 to $3.40 per share. The offer began Oct. 21, 2026, and is set to expire at 5:00 p.m. New York time on Nov. 19, 2026, unless extended or terminated.

The closing price of INVE Technologies shares on Nasdaq was $2.22 on Oct. 20, 2026. If fully subscribed, the buyback would represent approximately 24.7% to 29.4% of the company's issued and outstanding shares as of Oct. 19, 2026, depending on the final purchase price. The tender offer is part of a previously authorized $40 million share repurchase program.

The company said it will fund the repurchase using cash on hand. The offer is not conditioned on financing or a minimum number of shares tendered. INVE Technologies reserves the right to purchase up to an additional 2% of outstanding shares above the $20 million threshold without extending the offer period.

Craig-Hallum Capital Group LLC is serving as the exclusive dealer manager. D.F. King & Co., Inc. is the information agent, and Equiniti Trust Company, LLC is the depositary. The company's directors and executive officers have indicated they do not plan to tender their shares.

Separately, INVE Technologies released preliminary unaudited financial results for the third quarter ended Sept. 30, 2026. The company expects revenue between $2.9 million and $3.1 million, gross margin of 18% to 19%, and net income of $0.4 million to $0.8 million, or $0.01 to $0.02 per share. The company reported a cash balance of $87.1 million as of Sept. 30, 2026. The preliminary results reflect the closing of an asset sale transaction with Trackonomy Systems, Inc. on Sept. 15, 2026. Final third-quarter results are expected on or about Nov. 12, 2026.

You May Also Be Interested In

• Meta's Muse AI to counter China models with subscribers, not ads, Alexandr Wang says - Nikkei
• Accenture shares fall on insider sales and analyst downgrade
• Booz Allen Hamilton falls despite earnings beat